Risk management strategies include the identification of susceptible populations, development of biomarkers of exposure or effect, and the use of chemical alternatives with reduced potential for harmful bioactivation. Regulatory agencies may also set exposure limits and require thorough testing for bioactivation potential as part of the safety assessment process.
